H.C

HC Wainwright on Friday affirmed its buy rating and $15.00 price target on Biophytis SA (NASDAQ:BPTS) stock, following the company’s announcement that it has received FDA approval to begin a Phase 2 clinical study. The study, which will…

On Friday, HC Wainwright reaffirmed a Buy rating on biopharmaceutical company argenx SE (NASDAQ: ARGX), with a firm price target of $448.00. The Company's confidence in argenx is rooted in the Company's successful introduction of…

Analysts at HC Wainwright said the crypto winter of 2022 no longer had any impact on related stocks. HC Wainwright believes the crypto winter is over and has called for a buy on Coinbase (NASDAQ:COIN) stock. According to the New…